HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Boyan, B. D. Articles by Schwartz, Z. Search for Related Content PubMed PubMed Citation Articles by Boyan, B. D. Articles by Schwartz, Z.

Response of Musculoskeletal Cells to Biomaterials

Dr. Boyan is Professor and Price Gilbert, Jr, Chair in Tissue Engineering, Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Georgia Institute of Technology, Atlanta, GA. Dr. Schwartz is Professor, Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech, Emory University, Georgia Institute of Technology.

Dr. Boyan or the department with which she is affiliated has received research or institutional support from Musculoskeletal Transplant Foundation, Orthologic, Biomimetic Pharmaceuticals, DePuy Germany, and EBI LP. Dr. Boyan or the department with which she is affiliated has received nonincome support (such as equipment or services), commercially derived honoraria, or other non-research–related funding (such as paid travel) from Institut Straumann. Dr. Boyan or the department with which she is affiliated has received royalties from OsteoBiologics, Inc. Dr. Boyan or the department with which she is affiliated has stock or stock options held in OsteoBiologics, Inc, and Orthonics, Inc. Dr. Boyan or the department with which she is affiliated serves as a consultant to or is an employee of Arthrocare, Inc, and IsoTis, Inc. Dr. Schwartz or the department with which he is affiliated has received research or institutional support from Musculoskeletal Transplant Foundation, Biomimetic Pharmaceuticals, DePuy Germany, Institut Straumann, and Impliant. Dr. Schwartz or the department with which he is affiliated has received royalties from OsteoBiologics, Inc. Dr. Schwartz or the department with which he is affiliated has stock or stock options held in OsteoBiologics, Inc.

Many of our current therapies are based on information obtained in cell cultures using substrates that have little in common with the substrates the cells will encounter in vivo. To produce materials that are clinically valuable, we must analyze more deeply how musculoskeletal cells interact with the physical features of their environments. An increasing body of information has examined the mechanisms by which osteoblasts interact with their substrate. The underlying substrate, particularly in bone, also has structural features that can alter the mechanical environment experienced by the cells. These structural features modulate the nature of cell attachment and the resulting cell shape, affecting cell proliferation and differentiation. The chemistry, surface energy, and microarchitecture of a material all influence the kinds of proteins that adsorb onto the surface, which in turn affects integrin-mediated attachment. Signaling via integrins initiates the transfer of information to the cell about the microenvironment. Cells can differentiate between crystallinities of the same chemistry and distinguish complex differences in surface structure. These differences in the in vitro response correspond to differences in clinical effectiveness. By designing biomaterials that maximally enhance mesenchymal cell attachment, migration, proliferation, and differentiation, the value of these materials for tissue repair will be markedly increased. The goal is to provide materials that are capable of supporting tissue regeneration in vivo, often at sites compromised by infection and loss of structure.